LinkedIn



Judith A. Aberg, MD

Posted December 2008

Judith Aberg serves as the Director of Virology at Bellevue Hospital Center, is an Associate Professor of Medicine at NYU School of Medicine in New York City, and is the Principal Investigator, AIDS Clinical Trials Unit; remarkably, she has been able to integrate these functions into improving HIV health outcomes, not only for her own patients but for countless other PLWHA in New York State who are affected by her efforts and involvement in treatment and care.

Dr. Aberg has been a leader in HIV clinical care and research for over a decade, securing a national reputation with a combination of advocacy, fierce intelligence, and commitment. Her experiences in research and data management have augmented her engagement in treatment issues. She has been a firm advocate for using evidence to support decision-making, in the context of both guidelines and quality measures, whether addressing population-based treatment or that of an individual patient. Her strong voice and persistence have led to productive outcomes.

As an active participant in the AIDS Institute’s guidelines committee for the care of HIV-infected adults, Dr. Aberg has been able to balance the detail of guidelines recommendations with the larger context of patient care. She has written guidelines on mycobacterial infections and ARV therapy. She has the ability to recognize how guidelines are practiced in an active clinical environment and can therefore shape the discussion by references to real case scenarios. Her input challenges her colleagues to consider other opinions and viewpoints, generating thoughtful discussion and reconsideration of policies and guidelines.

Dr. Aberg has written extensively about a wide range of topics in HIV care, including opportunistic infections and the effects of ARV medications. She has lectured on AIDS topics at venues around the world. On the national scene, Dr. Aberg is Chair of the Primary Care of HIV guidelines committee of the Infectious Disease Society of America and a member of the DHHS working group for guidelines on the therapy of HIV-Related Opportunistic Infections. She also serves as co-chair of the NCQA/AMA/HRSA/HIVMA combined performance measures panel.

Passionate as an instructor, she is actively involved with clinical duties and seeing patients, where she is able to apply her expert knowledge of current research. Dr. Judith Aberg is known for her intellectual rigor, her commitment to scientific evidence-based clinical practice, and her excellence in clinical care.